Smartlens, Inc

Transforming eye care through groundbreaking monitoring and treatment technologies. Smartlens is developing novel solutions for managing glaucoma and other anterior segment eye diseases. We are transforming traditional eye care into personalized, proactive disease management through our technologies addressing unmet needs in eye care since the 1950s, with solutions designed for millions of patients worldwide. Our comprehensive platform combines: • Breakthrough, electronics-free contact lens for remote IOP monitoring - addressing a primary risk factor for glaucoma, the leading cause of irreversible blindness • Smart drug delivery platform that optimizes treatment timing and patient compliance • Advanced AI-powered imaging platform serving as a smart slit lamp for remote disease management Protected by patents in over 40 countries and backed by prominent VC firms and Stanford University, our solutions have demonstrated strong clinical results with commercialization planned for 2026. Recognized by Nature Medicine, Fortune, and BBC, Smartlens received the "Outstanding Innovation in Medical Technology and Life Sciences" award at the 2021 High-Tech Awards. Smartlens is committed to building a world where eye diseases no longer compromise quality of life, ensuring better outcomes for patients globally.